Arbutus Biopharma Corp (NASDAQ:ABUS)

8.90
Delayed Data
As of 12:52pm ET
 +0.0547 / +0.62%
Today’s Change
3.45
Today|||52-Week Range
12.60
+76.33%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close8.85
Today’s open8.80
Day’s range8.75 - 9.03
Volume84,223
Average volume (3 months)390,747
Market cap$490.3M
Data as of 12:52pm ET, 08/16/2018

Growth & Valuation

Earnings growth (last year)+78.45%
Earnings growth (this year)+23.40%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+617.64%
P/E ratioNM
Price/Sales25.83
Price/Book3.67

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+0.08+1.91%
DRRXDURECT Corp+0.04+3.08%
CPRXCatalyst Pharmaceuti...+0.01+0.35%
PETXAratana Therapeutics...+0.21+4.22%
Data as of 1:11pm ET, 08/16/2018

Financials

Next reporting dateNovember 8, 2018
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$10.7M
Annual profit (last year)-$84.4M
Net profit margin-788.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer
David C. Hastings
Corporate headquarters
Burnaby, British Columbia

Forecasts